Table 1. Details of liver cancer cell lines.
| Cell line | Gender | Ethnicity | Age | Primary tumor | Cluster | Viral status | Preoperative treatment | Reference | Year of publication |
|---|---|---|---|---|---|---|---|---|---|
| Alexander cells | M | Black | 24 | Hepatoma | A | HBV+ | no | 13 | 1976 |
| C3A | M | Caucasian | 15 | Differentiated HCC | A | non | no | 14 | 1979 |
| Hep 3B2.1–7 | M | Black | 8 | Differentiated HCC | A | HBV+ | no | 14 | 1979 |
| Hep G2 | M | Black | 15 | Differentiated HCC | A | non | no | 14 | 1979 |
| huH1 | M | Asian | 53 | Hepatoma | A | HBV+ | no | 15 | 1981 |
| HuH6 | M | Asian | Infant | Hepatoblastoma | A | non | no | 16 | 1976 |
| HuH7 | M | Asian | 57 | Well-differentiated HCC | A | non | no | 17 | 1982 |
| JHH5 | M | Asian | 50 | HCC | A | non | no | 18 | 1990 |
| JHH7 | M | Asian | 53 | HCC | A | HBV+ | no | 18 | 1990 |
| PLC_PRF_5 | M | Black | 24 | Hepatoma | A | HBV+ | no | 13 | 1976 |
| HLE | M | Asian | 68 | Undifferentiated HCC | B | non | no | 19 | 1975 |
| HLF | M | Asian | 68 | Undifferentiated HCC | B | non | no | 19 | 1975 |
| JHH2 | M | Asian | 57 | HCC | B | non | no | 18 | 1990 |
| JHH4 | M | Asian | 51 | HCC | B | non | no | 18 | 1990 |
| Li7 | M | Asian | 45 | Thick trabecular HCC | B | non | no | 20 | 1979 |
| SNU182 | M | Asian | 24 | HCC, grade III/IV | B | HBV+ | no | 21 | 1995 |
| SNU387 | F | Asian | 41 | HCC, grade III-IV/IV | B | HBV+ | TACE | 21 | 1995 |
| SNU423 | M | Asian | 40 | HCC, grade III/IV | B | HBV+ | TACE | 21 | 1995 |
| SNU449 | M | Asian | 52 | HCC, grade II-III/IV | B | HBV+ | no | 21 | 1995 |
| SNU475 | M | Asian | 43 | HCC, grade III-IV/IV | B | HBV+ | no | 21 | 1995 |
| SNU761 | M | Asian | 49 | HCC, grade III/IV | B | HBV+ | TAE | 22 | 1999 |
| SNU878 | F | Asian | 54 | HCC, grade II III/IV | B | HBV+ | TAE | 22 | 1999 |
| SNU886 | M | Asian | 57 | HCC, grade II IV/IV | B | HBV+ | TAE | 22 | 1999 |
| JHH1 | M | Asian | 50 | HCC, Ed. III | C | non | no | 23 | 1985 |
| JHH6 | F | Asian | 57 | HCC, Ed. II | C | non | no | 18 | 1990 |
| NCIH648 | M | Caucasian | 55 | Adenocarcinoma* | C | non | no | 24 | 1987 |
| SKHEP1 | M | Caucasian | 52 | Adenocarcinoma | C | non | NA | 25 | 1977 |
| SNU398 | M | Asian | 42 | HCC | C | HBV+ | TACE | 21 | 1995 |
*Although NCIH648 is classified as liver cancer in CCLE, it was established from the liver metastatic tumor of colon cancer.
Abbreviations: HBV, hepatitis B virus; HCC, hepatocellular carcinoma.
TAE; transarterial embolization, TACE; transarterial chemoembolization.